Compare · ELV vs FTRE
ELV vs FTRE
Side-by-side comparison of Elevance Health Inc. (ELV) and Fortrea Holdings Inc. (FTRE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and FTRE operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.91B, about 43.0x FTRE ($2.16B).
- FTRE has been more active in the news (5 items in the past 4 weeks vs 3 for ELV).
- FTRE has more recent analyst coverage (25 ratings vs 23 for ELV).
- Company
- Elevance Health Inc.
- Fortrea Holdings Inc.
- Price
- $428.56+0.04%
- $22.51-1.14%
- Market cap
- $92.91B
- $2.16B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 3
- 5
- Recent ratings
- 23
- 25
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
Latest FTRE
- Fortrea upgraded by Deutsche Bank with a new price target
- Fortrea upgraded by Barclays with a new price target
- Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call
- Fortrea Holdings Inc. filed SEC Form 8-K: Leadership Update
- UBS initiated coverage on Fortrea with a new price target
- SEC Form 4 filed by Chief Financial Officer Knoblauch Jason Fredrick
- Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Interim CAO Russell Carrie Elizabeth converted options into 850 shares and sold $4,145 worth of shares (246 units at $16.85), increasing direct ownership by 34% to 2,384 units (SEC Form 4) (tax liability)
- Chief Operating Officer Morais Mark A. sold $53,061 worth of shares (3,149 units at $16.85) and converted options into 7,157 shares, increasing direct ownership by 5% to 81,794 units (SEC Form 4) (withholding obligation)
- Fortrea to Participate in September Investor Conferences